Bath & Body Works (NYSE:BBWI) Issues Q3 2025 Earnings Guidance

Key Points

• Bath & Body Works has updated its Q3 2025 earnings guidance, projecting EPS between $0.370-$0.450, below the consensus estimate of $0.490, and revenue guidance of $1.6 billion-$1.7 billion.
• The company has recently declared a quarterly dividend of $0.20 per share, translating to an annualized dividend of $0.80 and a dividend yield of 2.5%.
• Institutional investors hold approximately 95.14% of Bath & Body Works stock, indicating strong support from hedge funds and other large investors.

Bath & Body Works (NYSE:BBWI - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.370-0.45 for the period, compared to the consensus estimate of 0.490. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion. Bath & Body Works also updated its FY 2025 guidance to 3.350-3.600 EPS.

Bath & Body Works Stock Down 0.4%

Shares of BBWI stock traded down $0.13 during trading on Monday, hitting $29.23. The company had a trading volume of 6,942,370 shares, compared to its average volume of 5,505,582. The stock's 50-day moving average is $30.63 and its two-hundred day moving average is $30.74. The stock has a market capitalization of $6.03 billion, a price-to-earnings ratio of 8.67, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49. Bath & Body Works has a 52 week low of $24.94 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same period last year, the business earned $0.37 earnings per share. The business's quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.

Analyst Ratings Changes

A number of analysts have recently weighed in on BBWI shares. Barclays increased their price objective on Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research note on Friday. The Goldman Sachs Group lowered their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. JPMorgan Chase & Co. raised their price objective on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Wells Fargo & Company raised their price target on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $41.62.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Geneos Wealth Management Inc. lifted its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after buying an additional 801 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Bath & Body Works by 155.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 4,456 shares of the company's stock worth $134,000 after purchasing an additional 2,714 shares in the last quarter. State of Wyoming lifted its holdings in Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company's stock worth $338,000 after purchasing an additional 661 shares in the last quarter. Oxford Asset Management LLP purchased a new position in Bath & Body Works in the 2nd quarter worth approximately $340,000. Finally, Gamco Investors INC. ET AL purchased a new position in Bath & Body Works in the 2nd quarter worth approximately $445,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.